By: Peter Ciszewski| Published on: Aug 7, 2020
Ari Zimran, MD from the Shaare Zedek Medical Center in Israel discusses the impact the COVID-19 pandemic has had on treating patients with lysosomal storage disorders that require enzyme replacement therapies.
This presentation was part the live GRIDS 2020-Virtual Summit held July 1, 2020 and is now available exclusively on CheckRare.
To view the entire session and receive CME credit, go to checkrare.com/learning/p-grids2020-module4-lysosomal-disease-management-and-covid-19/
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |